INFeD (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the INFeD drug offered from Actavis Pharma, Inc.. This Iron [Chemical/Ingredient],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
NON-PROPRIETARY NAME: | Iron Dextran |
SUBSTANCE NAME: | IRON DEXTRAN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Iron [Chemical/Ingredient],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] |
ROUTE: | INTRAMUSCULAR; INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1974-04-29 |
END MARKETING DATE: | 0000-00-00 |
INFeD HUMAN PRESCRIPTION DRUG Details:
Item Description | INFeD from Actavis Pharma, Inc. |
LABELER NAME: | Actavis Pharma, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/mL) |
START MARKETING DATE: | 1974-04-29 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 52544-931_aead060b-cb47-4163-a1d8-8829837f2952 |
PRODUCT NDC: | 52544-931 |
APPLICATION NUMBER: | NDA017441 |
Other IRON DEXTRAN Pharmaceutical Manufacturers / Labelers: